51 related articles for article (PubMed ID: 2014933)
1. Improved stability in oral delivery of albuterol provides less variability in bronchodilation in adults with asthma.
Grossman J; Morris RJ; White KD; Cocchetto DM
Ann Allergy; 1991 Apr; 66(4):324-7. PubMed ID: 2014933
[TBL] [Abstract][Full Text] [Related]
2. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
3. Albuterol extended-release products: a comparison of steady-state pharmacokinetics.
Hussey EK; Donn KH; Powell JR
Pharmacotherapy; 1991; 11(2):131-5. PubMed ID: 2052468
[TBL] [Abstract][Full Text] [Related]
4. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
6. Duration of action of oral albuterol in an asthmatic population.
Rosen JP; Chervinsky P; Renard RL; Kemp JP; Mendelson LM; Selcow JE; Noyes JH; Meltzer EO; Welch MJ; Orgel HA
Ann Allergy; 1986 Jan; 56(1):28-33. PubMed ID: 3511776
[TBL] [Abstract][Full Text] [Related]
7. Isoetharine versus albuterol for acute asthma: greater immediate effect, but more side effects.
Shrestha M; Gourlay S; Robertson S; Bidadi K; Wainscott M; Hayes J
Am J Med; 1996 Mar; 100(3):323-7. PubMed ID: 8629678
[TBL] [Abstract][Full Text] [Related]
8. Proventil HFA provides bronchodilation comparable to ventolin over 12 weeks of regular use in asthmatics.
Bleecker ER; Tinkelman DG; Ramsdell J; Ekholm BP; Klinger NM; Colice GL; Slade HB
Chest; 1998 Feb; 113(2):283-9. PubMed ID: 9498940
[TBL] [Abstract][Full Text] [Related]
9. Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring.
Kemp JP; Bierman CW; Cocchetto DM
Ann Allergy; 1993 Apr; 70(4):316-22. PubMed ID: 8466097
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma.
Brookman LJ; Knowles LJ; Barbier M; Elharrar B; Fuhr R; Pascoe S
Curr Med Res Opin; 2007 Dec; 23(12):3113-22. PubMed ID: 17999782
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].
Beeh KM; Beier J; Kornmann O; Wiewrodt R; Buhl R;
Pneumologie; 2002 Feb; 56(2):91-7. PubMed ID: 11842346
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
Hordvik NL; Sammut PH; Judy CG; Colombo JL
Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
[TBL] [Abstract][Full Text] [Related]
13. A random double-blind trial of the combination of nebulized atropine methylnitrate and albuterol in nocturnal asthma.
Sur S; Mohiuddin AA; Vichyanond P; Nelson HS
Ann Allergy; 1990 Nov; 65(5):384-8. PubMed ID: 2244710
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilation using combined urodilatin - albuterol administration in asthma: a randomized, double-blind, placebo-controlled trial.
Flüge T; Forssmann WG; Kunkel G; Schneider B; Mentz P; Forssmann K; Barnes PJ; Meyer M
Eur J Med Res; 1999 Oct; 4(10):411-5. PubMed ID: 10527954
[TBL] [Abstract][Full Text] [Related]
15. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
Orgel HA; Kemp JP; Tinkelman DG; Webb DR
J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
[TBL] [Abstract][Full Text] [Related]
16. Bambuterol: a new long acting bronchodilating prodrug.
Vilsvik JS; Langaker O; Persson G; Ringdal N; Schaanning J; Kvelstad G; Svensson K; Holthe S; Soliman S
Ann Allergy; 1991 Apr; 66(4):315-9. PubMed ID: 2014931
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the acute cardiopulmonary effects of oral albuterol, metaproterenol, and terbutaline in asthmatics.
Wolfe JD; Yamate M; Biedermann AA; Chu TJ
JAMA; 1985 Apr; 253(14):2068-72. PubMed ID: 3974097
[TBL] [Abstract][Full Text] [Related]
18. Albuterol extended-release products: effect of food on the pharmacokinetics of single oral doses of Volmax and Proventil Repetabs in healthy male volunteers.
Hussey EK; Donn KH; Powell JR; Lahey AP; Pakes GE
J Clin Pharmacol; 1991 Jun; 31(6):561-4. PubMed ID: 1880222
[TBL] [Abstract][Full Text] [Related]
19. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.
Handley DA; Tinkelman D; Noonan M; Rollins TE; Snider ME; Caron J
J Asthma; 2000 Jun; 37(4):319-27. PubMed ID: 10883742
[TBL] [Abstract][Full Text] [Related]
20. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol.
Nelson HS; Spector SL; Whitsett TL; George RB; Dwek JH
J Allergy Clin Immunol; 1983 Oct; 72(4):371-5. PubMed ID: 6352780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]